Ludwig Center, University of Lausanne , Epalinges , Switzerland.
Front Immunol. 2013 Jul 30;4:218. doi: 10.3389/fimmu.2013.00218. eCollection 2013.
T cells constitute the core of adaptive cellular immunity and protect higher organisms against pathogen infections and cancer. Monitoring of disease progression as well as prophylactic or therapeutic vaccines and immunotherapies call for conclusive detection, analysis, and sorting of antigen-specific T cells. This is possible by means of soluble recombinant ligands for T cells, i.e., MHC class I-peptide (pMHC I) complexes for CD8(+) T cells and MHC class II-peptide (pMHC II) complexes for CD4(+) T cells and flow cytometry. Here we review major developments in the development of pMHC staining reagents and their diverse applications and discuss perspectives of their use for basic and clinical investigations.
T 细胞构成适应性细胞免疫的核心,保护高等生物免受病原体感染和癌症的侵害。疾病进展的监测以及预防性或治疗性疫苗和免疫疗法都需要对抗原特异性 T 细胞进行明确的检测、分析和分选。这可以通过可溶性重组 T 细胞配体来实现,即 MHC Ⅰ类肽(pMHCⅠ)复合物用于 CD8(+)T 细胞,MHC Ⅱ类肽(pMHCⅡ)复合物用于 CD4(+)T 细胞和流式细胞术。在这里,我们回顾了 pMHC 染色试剂的主要发展及其各种应用,并讨论了它们在基础和临床研究中的应用前景。